399 related articles for article (PubMed ID: 30617121)
21. Leads from the MMWR. Influenza vaccine composition recommendation for the 1989-90 season.
JAMA; 1989 Apr; 261(15):2183. PubMed ID: 2926955
[No Abstract] [Full Text] [Related]
22. A vaccine combination of lipid nanoparticles and a cholera toxin adjuvant derivative greatly improves lung protection against influenza virus infection.
Bernasconi V; Norling K; Gribonika I; Ong LC; Burazerovic S; Parveen N; Schön K; Stensson A; Bally M; Larson G; Höök F; Lycke N
Mucosal Immunol; 2021 Mar; 14(2):523-536. PubMed ID: 32807838
[TBL] [Abstract][Full Text] [Related]
23. Advances in the development of universal influenza vaccines.
Gilbert SC
Influenza Other Respir Viruses; 2013 Sep; 7(5):750-8. PubMed ID: 22998622
[TBL] [Abstract][Full Text] [Related]
24. Towards a universal influenza vaccine: different approaches for one goal.
Sautto GA; Kirchenbaum GA; Ross TM
Virol J; 2018 Jan; 15(1):17. PubMed ID: 29370862
[TBL] [Abstract][Full Text] [Related]
25. Targeting B cell responses in universal influenza vaccine design.
Kaur K; Sullivan M; Wilson PC
Trends Immunol; 2011 Nov; 32(11):524-31. PubMed ID: 21940217
[TBL] [Abstract][Full Text] [Related]
26. Impact of influenza B lineage-level mismatch between trivalent seasonal influenza vaccines and circulating viruses, 1999-2012.
Heikkinen T; Ikonen N; Ziegler T
Clin Infect Dis; 2014 Dec; 59(11):1519-24. PubMed ID: 25139969
[TBL] [Abstract][Full Text] [Related]
27. Universal or Specific? A Modeling-Based Comparison of Broad-Spectrum Influenza Vaccines against Conventional, Strain-Matched Vaccines.
Subramanian R; Graham AL; Grenfell BT; Arinaminpathy N
PLoS Comput Biol; 2016 Dec; 12(12):e1005204. PubMed ID: 27977667
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal Antibody Responses after Recombinant Hemagglutinin Vaccine versus Subunit Inactivated Influenza Virus Vaccine: a Comparative Study.
Henry C; Palm AE; Utset HA; Huang M; Ho IY; Zheng NY; Fitzgerald T; Neu KE; Chen YQ; Krammer F; Treanor JJ; Sant AJ; Topham DJ; Wilson PC
J Virol; 2019 Nov; 93(21):. PubMed ID: 31434733
[TBL] [Abstract][Full Text] [Related]
29. Prospects for universal influenza virus vaccine.
Gerhard W; Mozdzanowska K; Zharikova D
Emerg Infect Dis; 2006 Apr; 12(4):569-74. PubMed ID: 16704803
[TBL] [Abstract][Full Text] [Related]
30. Next-Generation Influenza HA Immunogens and Adjuvants in Pursuit of a Broadly Protective Vaccine.
Nagashima KA; Mousa JJ
Viruses; 2021 Mar; 13(4):. PubMed ID: 33805245
[TBL] [Abstract][Full Text] [Related]
31. Report on eighth WHO meeting on development of influenza vaccines that induce broadly protective and long-lasting immune responses: Chicago, USA, 23-24 August 2016.
Ortiz JR; Hickling J; Jones R; Donabedian A; Engelhardt OG; Katz JM; Madhi SA; Neuzil KM; Rimmelzwaan GF; Southern J; Spiro DJ; Hombach J
Vaccine; 2018 Feb; 36(7):932-938. PubMed ID: 29221895
[TBL] [Abstract][Full Text] [Related]
32. Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease?
Neu KE; Henry Dunand CJ; Wilson PC
Curr Opin Immunol; 2016 Oct; 42():48-55. PubMed ID: 27268395
[TBL] [Abstract][Full Text] [Related]
33. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2018-19 Influenza Season.
Grohskopf LA; Sokolow LZ; Broder KR; Walter EB; Fry AM; Jernigan DB
MMWR Recomm Rep; 2018 Aug; 67(3):1-20. PubMed ID: 30141464
[TBL] [Abstract][Full Text] [Related]
34. Estimating Vaccine-Driven Selection in Seasonal Influenza.
Wen FT; Bell SM; Bedford T; Cobey S
Viruses; 2018 Sep; 10(9):. PubMed ID: 30231576
[TBL] [Abstract][Full Text] [Related]
35. Is It Possible to Develop a "Universal" Influenza Virus Vaccine? Potential Target Antigens and Critical Aspects for a Universal Influenza Vaccine.
Krammer F; García-Sastre A; Palese P
Cold Spring Harb Perspect Biol; 2018 Jul; 10(7):. PubMed ID: 28663209
[TBL] [Abstract][Full Text] [Related]
36. Influenza vaccines.
Brede HD
Int Arch Allergy Immunol; 1995 Dec; 108(4):318-20. PubMed ID: 7580301
[TBL] [Abstract][Full Text] [Related]
37. Downfall of the current antibody correlates of influenza vaccine response in yearly vaccinated subjects: Toward qualitative rather than quantitative assays.
Cagigi A; Cotugno N; Rinaldi S; Santilli V; Rossi P; Palma P
Pediatr Allergy Immunol; 2016 Feb; 27(1):22-7. PubMed ID: 26480951
[TBL] [Abstract][Full Text] [Related]
38. Influenza vaccination strategies targeting the hemagglutinin stem region.
Fukuyama H; Shinnakasu R; Kurosaki T
Immunol Rev; 2020 Jul; 296(1):132-141. PubMed ID: 32542739
[TBL] [Abstract][Full Text] [Related]
39. Seasonal influenza vaccination and technologies.
Nafziger AN; Pratt DS
J Clin Pharmacol; 2014 Jul; 54(7):719-31. PubMed ID: 24691877
[TBL] [Abstract][Full Text] [Related]
40. Diminished B-Cell Response After Repeat Influenza Vaccination.
Sanyal M; Holmes TH; Maecker HT; Albrecht RA; Dekker CL; He XS; Greenberg HB
J Infect Dis; 2019 Apr; 219(10):1586-1595. PubMed ID: 30496437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
